Forest Labs #39; new hypertension drug disappoints in efficacy study NEW YORK, November 2 (newratings.com) - Forest Laboratories Inc (FRX.NYS) witnessed a decline in its share price this morning, following the news of disappointing efficacy study results for the company #39;s new hypertension drug.